Optos, PLC
21
2
3
11
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
3 terminated/withdrawn out of 21 trials
78.6%
-7.9% vs industry average
0%
0 trials in Phase 3/4
18%
2 of 11 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (21)
Glaucoma Evaluation With the P200TE
Role: lead
Data Gathering for A10900
Role: lead
Retinal Investigation Using Optos OCT Device
Role: lead
P200TxE Diseased Eye Image Collection
Role: lead
Study Comparing the P200TxE and P200DTx
Role: lead
P200TE US Reference Database Study
Role: lead
Data Collection With the P200TE and P200TxE
Role: lead
Optic Disc Photograph Collection Study
Role: lead
P200TE and Predicate Agreement and Precision Study
Role: lead
P200TE Agreement and Precision Study
Role: lead
Study Comparing the P200TE and the P200TxE in Glaucoma Patients
Role: lead
ARDA Software for the Detection of mtmDR
Role: collaborator
REtinaL Imaging & Ambulatory BLood PrEssure
Role: collaborator
Navigated OCT Imaging With the P200TxE
Role: lead
Image Collection of Normal Eyes for Development of an EU RDB
Role: lead
Sub-threshold Photocoagulation of Diabetic Macular Oedema
Role: collaborator
Optos P200TE Agreement and Precision Study
Role: lead
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Role: lead
Side-by-Side Comparison of P200TE and Spectral OCT/SLO on Diseased Eyes
Role: lead
ObseRvation of PeripHEral rEtinal Morphology in Normals
Role: lead